RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 62 filers reported holding RECRO PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,000 | +33.3% | 337 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -99.0% | 337 | -99.3% | 0.00% | -100.0% |
| Q1 2019 | $300,000 | -18.9% | 51,261 | -1.6% | 0.02% | -32.0% |
| Q4 2018 | $370,000 | +20.9% | 52,076 | +21.1% | 0.02% | +38.9% |
| Q3 2018 | $306,000 | +168.4% | 42,995 | +89.7% | 0.02% | +157.1% |
| Q2 2018 | $114,000 | -57.1% | 22,665 | -6.2% | 0.01% | -63.2% |
| Q1 2018 | $266,000 | +442.9% | 24,165 | +245.2% | 0.02% | +280.0% |
| Q2 2017 | $49,000 | -70.8% | 7,000 | -66.5% | 0.01% | -75.0% |
| Q4 2016 | $168,000 | +2000.0% | 20,879 | +2219.9% | 0.02% | +1900.0% |
| Q4 2015 | $8,000 | +60.0% | 900 | +125.0% | 0.00% | 0.0% |
| Q3 2015 | $5,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |